(S)-N-(5-Chlorothiophene-2-sulfonyl)-β,β-diethylalaninol a Notch-1-sparing γ-secretase inhibitor
Derek C. Cole, J. Steven Jacobsen, Yun Hu(Princeton University), David Riddell(Eli Lilly (United States)), David S. Casebier(Arqule (United States)), John W. Ellingboe(Pearl River Community College), George Diamantidis, Joseph R. Stock, Madelene Antane, Charles W. Mann(Princeton University), Mei Jin, Erik Wagner(Princeton University), June Sonnenberg‐Reines, Kevin R. Woller, Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), William Moore, Robert Martone(Princeton University), Anthony F. Kreft, Shaiu-Ching Sun, Dennis Kubrak, Zheng Wang(Princeton University), Zheng Xu(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine), Hua Zhou, Peimin Lu, Suzan H. Aschmies(Princeton University), Aram Oganesian(Plex Pharmaceuticals (United States)), Boyd L. Harrison, Thomas A. Comery(Princeton University)
Cited by 19
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302